Related Experiment Video
Updated: Sep 6, 2025
07:06
Fecal Microbiota Transplantation via Colonoscopy for Recurrent C. difficile Infection
Published on: December 8, 2014
27.2K
[A case of localized fasciitis with ulcerative colitis]
Kenichi Irie1, Takahisa Tateishi1, Shinsuke Hirano1
1Division of Respirology, Neurology and Rheumatology, Department of Medicine, Kurume University School of Medicine.
Rinsho Shinkeigaku = Clinical Neurology
|June 26, 2022
Summary
A patient with ulcerative colitis developed gastrocnemius myalgia syndrome, a rare complication causing leg pain and fasciitis, after starting salazosulfapyridine. Prompt treatment with prednisolone led to symptom resolution, highlighting the importance of recognizing this condition.
Area of Science:
- Gastroenterology
- Rheumatology
- Medical Imaging
Background:
- Ulcerative colitis (UC) is a chronic inflammatory bowel disease.
- Salazosulfapyridine is a common treatment for UC.
- Gastrocnemius myalgia syndrome (GMS) is a rare complication characterized by leg pain and fasciitis.
Observation:
- A 36-year-old male with UC presented with bloody stools, treated with salazosulfapyridine.
- Following treatment, he developed bilateral lower leg swelling and pain, indicative of fasciitis.
- MRI revealed characteristic inflammatory changes in the leg fascia and vasculature.
Findings:
- The patient was diagnosed with gastrocnemius myalgia syndrome, a condition rarely associated with UC.
- Treatment with oral prednisolone resulted in prompt resolution of pain and swelling.
- Symptom resolution was maintained during prednisolone tapering.
Implications:
- This case highlights the importance of considering GMS in UC patients presenting with leg pain and swelling, even if rare.
- Early recognition and treatment with corticosteroids can effectively manage GMS.
- Clinicians should be aware of GMS as a potential complication of UC treatment.
Related Concept Videos
01:27Inflammatory Bowel Disease I: Ulcerative Colitis
306
Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
306
01:30Inflammatory Bowel Disease II: Crohn's Disease
370
Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
370
01:17Chronic Bowel Disorders: Introduction
535
Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
535
01:29Drugs for Treatment of Ulcerative Colitis in IBD
232
Ulcerative colitis is a chronic inflammatory condition primarily affecting the colon and rectum. The primary drugs used in the treatment of ulcerative colitis are aminosalicylates. They exhibit anti-inflammatory and immunosuppressive properties. They modulate inflammatory mediators and inhibit the activity of nuclear factor κB (NF-κB). Aminosalicylates also reduce inflammation by inhibiting prostaglandin and leukotriene production and decreasing neutrophil chemotaxis and superoxide...
232
01:21Inflammatory Bowel Disease V: Surgical Management
200
Surgical interventions for inflammatory bowel disease (IBD), which includes ulcerative colitis and Crohn's disease, are essential in managing symptoms and addressing complications. The selection of surgical procedures is contingent upon the specific conditions and complications that stem from these illnesses.
Here are some common surgical interventions for IBD:
Here are some common surgical interventions for IBD:
200
01:30Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
403
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
403